Article
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: description of a new mutation, R384X.
Colombia medica (Cali, Colombia) - 30 Sept 2016
Matallana-Rhoades Audrey Mary, Corredor-Castro Juan David, Bonilla-Escobar Francisco Javier, Mecias-Cruz Bony Valentina, Mejia de Beldjena Liliana
Abstract excerpt
CASE DESCRIPTION: It is presented the phenotype of a new compound heterozygous mutation of the genes R384X and Q356X encoding the enzyme of 11-beta-hydroxylase. CLINICAL FINDINGS: Severe virilization, peripheral hypertension, and early puberty. TREATMENT AND OUTCOME: Managed with hormone replacement therapy (corticosteroid) and antihypertensive therapy (beta-blocker), resulting in the control of physical changes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
